Bovine lactoferrin suppresses the proliferation of endometriotic stromal cells via the PI3K/Akt/mTOR pathway
article
OA: closed
CC0
AI-generated summary
Bovine lactoferrin suppressed endometriotic stromal cell proliferation by arresting the cell cycle at G1 phase via inhibition of the PI3K/Akt/mTOR pathway and cyclin D1 synthesis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The most common medical therapy for endometriosis suppresses ovulation, which is a barrier for patients planning pregnancy. To address this issue, we focused on the cell proliferation-suppressing effects of lactoferrin, which reportedly in various malignant tumours. Despite being a benign disease, endometriotic cells have similar characteristics to malignant tumours, which may be involved in its onset and progression. Endometriotic and endometrial stromal cells were obtained from patients with endometriosis. After culture with 1 mg/mL of bovine lactoferrin, cell proliferation was significantly suppressed in endometriotic stromal cells compared to controls, but this remained unchanged in endometrial stromal cells. Bovine lactoferrin also significantly increased the number of endometriotic stromal cells in the G0/G1 phase and significantly decreased those in the S phase, and suppressed the protein expression of phosphorylated-AKT, phosphorylated-mTOR, phosphorylated-S6K, and cyclin D1. Bovine lactoferrin inhibits the transition from the G1 to the S phase by suppressing the PI3K/Akt/mTOR pathway and reducing the synthesis of cyclin D1, thereby arresting the cell cycle at the G1 phase. Bovine lactoferrin suppressed the proliferation of endometriotic stromal cells without suppressing the proliferation of endometrial stromal cells. Lactoferrin, which allows for pregnancy and lactation during administration, has potential as a novel therapeutic candidate for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review) via openalex
- Chronic endometritis modifies decidualization in human endometrial stromal cells via openalex
- Differential regulation of Akt phosphorylation in endometriosis via openalex
- Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development via openalex
- Epithelial–Mesenchymal Transition in Endometriosis—When Does It Happen? via openalex
- Research advances in endometriosis-related signaling pathways: A review via openalex
- Role of cytokines in endometriosis via openalex
- The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression via openalex
- W2143486607 via openalex
- W2152065348 via openalex
- W2153569787 via openalex
- W2154111336 via openalex
- W2157100128 via openalex
- W2415859941 via openalex
- W2416581816 via openalex
- W2516931075 via openalex
- W2761875562 via openalex
- W2767678122 via openalex
- W2792174894 via openalex
- W2889427252 via openalex
- W3010658987 via openalex
- W3203436117 via openalex
- W4200537901 via openalex
- W4211081176 via openalex
- W1492850584 via openalex
- W4404647813 via openalex
- W1981361956 via openalex
- W2010759759 via openalex
- W2020014038 via openalex
- W2046867627 via openalex
- W2048527621 via openalex
- W2072503088 via openalex
- W2078399145 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-19T00:31:16.128783+00:00
License: CC0
· commercial use OK